Taken together, these studies suggest that the activity and the destiny of p53 and p53-related proteins can be regulated by the SUMO E3 enzyme, thereby promoting or suppressing the p53 activity, which plays important roles in cancer. This evidence concerns the gene TP53 and cancer.